Michelle N Eakin1, Kristin A Riekert. 1. Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Abstract
PURPOSE OF REVIEW: As new medications continue to come to market to improve health in individuals with cystic fibrosis (CF), patient adherence is increasingly more important to address. Currently, adherence for pulmonary medications is approximately 50% for people with CF. There has been recent research that has demonstrated that poor adherence is linked to worse health outcomes. This review summarizes recent research on the impact of adherence on lung health and highlights future areas of research and clinical practice to address this growing need. RECENT FINDINGS: Recent research has indicated that nonadherence is associated with increased hospitalizations and pulmonary exacerbations, lower baseline lung function, and longer length of stays. However, most of the research has been done using pharmacy refill records as an objective measure of adherence. Electronic monitoring of medications provides more detailed information about patterns of use, which can directly inform clinical care. Furthermore, there have been few published clinical trials evaluating behavioral interventions to promote adherence. SUMMARY: Given the recent research linking adherence to lung health outcomes, there is a growing need to measure and evaluate adherence in clinical care. As new medications are approved for CF, methods to monitor adherence also need to be developed and approved. Clinicians need to continue to assess barriers to adherence to be able to individually tailor interventions to a patient's needs.
PURPOSE OF REVIEW: As new medications continue to come to market to improve health in individuals with cystic fibrosis (CF), patient adherence is increasingly more important to address. Currently, adherence for pulmonary medications is approximately 50% for people with CF. There has been recent research that has demonstrated that poor adherence is linked to worse health outcomes. This review summarizes recent research on the impact of adherence on lung health and highlights future areas of research and clinical practice to address this growing need. RECENT FINDINGS: Recent research has indicated that nonadherence is associated with increased hospitalizations and pulmonary exacerbations, lower baseline lung function, and longer length of stays. However, most of the research has been done using pharmacy refill records as an objective measure of adherence. Electronic monitoring of medications provides more detailed information about patterns of use, which can directly inform clinical care. Furthermore, there have been few published clinical trials evaluating behavioral interventions to promote adherence. SUMMARY: Given the recent research linking adherence to lung health outcomes, there is a growing need to measure and evaluate adherence in clinical care. As new medications are approved for CF, methods to monitor adherence also need to be developed and approved. Clinicians need to continue to assess barriers to adherence to be able to individually tailor interventions to a patient's needs.
Authors: Eileen Savage; Paul V Beirne; Muireann Ni Chroinin; Alistair Duff; Tony Fitzgerald; Dawn Farrell Journal: Cochrane Database Syst Rev Date: 2011-07-06
Authors: Jerry A Krishnan; Bruce G Bender; Frederick S Wamboldt; Stanley J Szefler; N Franklin Adkinson; Robert S Zeiger; Robert A Wise; Andrew L Bilderback; Cynthia S Rand Journal: J Allergy Clin Immunol Date: 2011-11-21 Impact factor: 10.793
Authors: Christine L M Joseph; Dennis R Ownby; Suzanne L Havstad; Jacqueline Saltzgaber; Shannon Considine; Dayna Johnson; Ed Peterson; Gwen Alexander; Mei Lu; Wanda Gibson-Scipio; Christine Cole Johnson Journal: J Adolesc Health Date: 2012-09-27 Impact factor: 5.012
Authors: Michelle N Eakin; Andrew Bilderback; Michael P Boyle; Peter J Mogayzel; Kristin A Riekert Journal: J Cyst Fibros Date: 2011-03-31 Impact factor: 5.482
Authors: Rosemary Ball; Kevin W Southern; Pamela McCormack; Alistair J A Duff; Keith G Brownlee; Paul S McNamara Journal: J Cyst Fibros Date: 2013-01-29 Impact factor: 5.482
Authors: Melissa Basile; Lincy Jojan; Mara R Hobler; Elisabeth P Dellon; Anna M Georgiopoulos; Jessica L Goggin; Elaine Chen; Christopher H Goss; Sarah E Hempstead; Albert Faro; Dio Kavalieratos Journal: J Palliat Med Date: 2021-04-20 Impact factor: 2.947
Authors: Rebecca J Calthorpe; Sherie J Smith; Nicola J Rowbotham; Paul A Leighton; Gwyneth Davies; Tracey Daniels; Katie Gathercole; Lorna Allen; Zoe C Elliott; Alan R Smyth Journal: BMJ Open Respir Res Date: 2020-08